Inventor · disambiguated record
Andrew James Pow
Also filed as: POW ANDREW · POW ANDREW J · POW ANDREW JAMES
6 granted patents·12 pending applications·22 citations·filing 2009–2025
77Inventor score
Files withTEVA PHARMACEUTICALS AUSTRALIA PTY LTD7COMPUGEN LTD4ADALTA LTD2BAYER AG2CEPHALON AUSTRALIA PTY LTD1
Top patents by PatentIndex Score
18 records- 0190US10822422B2Antibodies against TL1a and uses thereofTEVA PHARMACEUTICALS AUSTRALIA PTY LTD·Filed 2016·Granted Nov 3, 2020·10 cites·13 claims
- 0287US2025353919A1Antibodies Against TL1A and Uses ThereofTEVA PHARMACEUTICALS AUSTRALIA PTY LTD·Filed 2025·Application pending·0 cites
- 0385US8563697B2Anti-IL-12/IL-23 antibodiesCLARKE ADAM WILLIAM·Filed 2009·Granted Oct 22, 2013·11 cites·11 claims
- 0483US12410256B2Antibodies that specifically bind to TL1a and methods of treating gastrointestinal or lung diseasesTEVA PHARMACEUTICALS AUSTRALIA PTY LTD·Filed 2023·Granted Sep 9, 2025·0 cites·19 claims
- 0573US11655297B2ILDR2 antagonists and combinations thereofBAYER AG·Filed 2018·Granted May 23, 2023·1 cites·18 claims
- 0672US2024287174A1Hide1 compositions and methodsCOMPUGEN LTD·Filed 2023·Application pending·0 cites
- 0768US2021347904A1Antibodies against tl1a and uses thereofTEVA PHARMACEUTICALS AUSTRALIA PTY LTD·Filed 2020·Application pending·0 cites
- 0864US2014255302A1ANTIBODIES AGAINST TL1a AND USES THEREOFTEVA PHARMACEUTICALS AUSTRALIA PTY LTD·Filed 2014·Application pending·0 cites
- 0959US11142588B2Polypeptides which bind C-X-C chemokine receptor type 4 (CXCR4) and methods of treating or reducing the risk of fibrosis and cancerADALTA LTD·Filed 2019·Granted Oct 12, 2021·0 cites·12 claims
- 1054US2016272707A1Vstm5 antibodies, and uses thereof for treatment of cancer, infectious diseases and immune related diseasesCOMPUGEN LTD·Filed 2014·Application pending·0 cites
- 1152US2014086922A1Anti-il-12/il-23 antibodiesCEPHALON AUSTRALIA PTY LTD·Filed 2013·Application pending·0 cites
- 1249US2022169736A1Combinations of anti-ildr2 antibodies and pd-1 antagonistsBAYER AG·Filed 2020·Application pending·0 cites
- 1348US2018305451A1Hide1 compositions and methodsCOMPUGEN LTD·Filed 2016·Application pending·0 cites
- 1447US2016264661A1Anti-il-12/il-23 antibodiesTEVA PHARMACEUTICALS AUSTRALIA PTY LTD·Filed 2016·Application pending·0 cites
- 1542US2014286957A1ANTIBODIES TO CD1dTEVA PHARMACEUTICALS AUSTRALIA PTY LTD·Filed 2014·Application pending·0 cites
- 1640US2014294765A1Lsr antibodies, and uses thereof for treatment of cancerCOMPUGEN LTD·Filed 2013·Application pending·0 cites
- 1736US10538596B2CXCR4 binding molecules and methods of use thereofADALTA LTD·Filed 2016·Granted Jan 21, 2020·0 cites·10 claims
- 1826US2012093811A1Anti-vegf-d antibodiesSIMMONDS JASON W·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Andrew James Pow files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →